Skip to main content

Table 2 Numbers of AEs and patients with AEs

From: Safety and efficiency of stem cell therapy for COVID-19: a systematic review and meta-analysis

Article

Numbers of patients with AEs, n(%), Experimental; Ctrl

Numbers of AEs, n, experimental; Ctrl

Numbers of patients with SAEs, n(%), experimental; Ctrl

Numbers of SAEs, n, experimental; Ctrl

Number of AEs related to teatment, n

Lanzoni et al. [15]

8(66.7) ; 11(91.67)

46 ; 53

2(16.7) ; 8(66.7)

6 ; 16

1*

Ventura-Carmenate et al. [16]**

50(72.5) ; 51(72.9)

107 ; 133

NR ; NR

NR ; NR

0

Torres Zambrano et al. [17]**

NR ; NR

NR ; NR

NR ; NR

NR ; NR

NR

Shi et al. [18]***

37(56.9) ; 21(60)

72 ; 36

1(1.5) ; 0

1 ; NR

0

Shi et al. [19]***

54(83.1) ; 26(74.3)

106 ; 54

1(1.5) ; 0

1 ; NR

0

Zhu et al. [20]

3(10.3) ; 13(44.8)

20 ; 34

0 ; 0

0 ; 0

0

Adas et al. [21]

NR ; NR

NR ; NR

NR ; NR

NR ; NR

NR

Dilogo et al. [22]

0 ; NR

0 ; NR

0 ; NR

0 ; NR

0

Torres Zambrano et al. [23]**

NR ; NR

NR ; NR

NR ; NR

NR ; NR

NR

Torres Zambrano et al. [24]**

NR ; NR

NR ; NR

NR ; NR

NR ; NR

NR

Wei et al. [25]

1(8.3) ; NR

3 ; NR

1(8.3) ; NR

3 ; NR

0

Xu et al. [26]

20(76.9) ; 18(100)

56 ; 59

NR ; NR

10 ; 15

0

Meng et al. [27]

3(33.3) ; NR

4 ; NR

0 ; NR

0 ; NR

3*

Häberle et al. [28]

NR ; NR

NR ; NR

NR ; NR

NR ; NR

NR

O.Ercelen et al. [29]

NR ; NR

NR; NR

0 ; NR

0 ; NR

0

Leng et al. [30]

NR ; NR

NR ; NR

0 ; NR

0 : NR

0

Shu et al. [31]

NR ; NR

NR ; NR

NR ; NR

NR ; NR

0

  1. AEs adverse events, SAEs serious adverse events
  2. *The former study [15] mentioned three “infusion associated events” during the first round of infusion. The latter study [27] reported number of AEs in relationship to treatment and only one AE was considered “Probable”, which is the highest degree in reported relationship.
  3. **These four studies are based on one clinical trial. The first study [16] focused on the safety and efficacy of stem cell therapy. The second study emphasized the radiographic outcome [17]. The third study [23] focused only on the renal involvement of the critically ill patients in the trial, and the last study [24] explored secondary sepsis and urinary tract infections in patients.
  4. ***These two studies are based on the same patients. The latter [19] is a one-year follow-up of the former and contains all AEs of the former [18].